Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update
Cannabis Law Report
NOVEMBER 12, 2021
” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose. both recognized leaders in emergency medicine. We recently announced a key milestone with the issuance of a method of use patent for ANEB-001, providing protection through 2040.
52 
Let's personalize your content